Inventurus Knowledge Solutions (IKS) is a healthcare services and technology company serving US providers through a Care Enablement Platform, revenue cycle management and clinical services, paid as a percentage of customer revenue. This will be the first quarter with the TruBridge acquisition inside reported numbers, so the print will speak to the guided pro forma EBITDA margin dip to 26-27% and the first consolidated TruBridge revenue contribution against its reset $300 Mn steady-state base.
| Results date | November 05, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 893.63 Cr |
| Previous quarter PAT | Rs. 193.74 Cr |
| Previous quarter EBITDA margin | 33.0% |
| Net debt (latest quarter) | Rs. 2,654 Mn (Jun 30, 2026) |
| Market cap | Rs. 29,641.08 Cr |
| CMP | Rs. 1,726.7 |
Inventurus Knowledge Solutions Limited is scheduled to report its Q2 FY 2026-2027 financial results on November 05, 2026.
The Board did not recommend any dividend for FY 2025-26, per the FY26 annual report announcement of August 28, 2026.
The Q2 FY27 print is the first with TruBridge inside reported numbers following the July 9, 2026 completion, adding a reset $300 Mn steady-state revenue base for roughly 2.7 months of the quarter on top of a legacy engine that grew 20.7% YoY in Q1 FY27. Management has already guided the margin shape: a pro forma EBITDA margin dip to 26-27% immediately post-TruBridge versus 33.0% in Q1 FY27, rebuilding toward early-to-mid 30s over the next couple of years.
Below the EBITDA line, the USD 635 Mn acquisition debt adds roughly Rs. 45-55 Cr of quarterly interest from Q2 onwards, pressuring PAT. The forex gain/(loss) line is the swing item, with headline EBITDA stated after forex and only 50-60% hedge cover; it collapsed to Rs. 12 Mn in Q1 FY27 from Rs. 352 Mn in Q4 FY26, while the rupee traded in the mid-95s to near-97 through July-September.
The key organic test is legacy constant-currency growth against the 'north of 12% CC' aspiration, which management explicitly calls an aspiration, not a guidance, with the CFO noting 'the entire growth in EBITDA has been driven by operational improvements and not by currency'. The call is also expected to address the quantified TrueBridge growth aspiration promised within two to three quarters of the August 6, 2026 call, possibly as early as this one.
Guidance scorecard to probe: Management laid out multiple open-ended targets on the Q1 FY27 call; Q2 FY27 is the first quarter to test them with TruBridge consolidated.
First consolidated margin with TruBridge inside
TruBridge first print and integration milestones
Deleveraging path
Legacy engine, concentration and one-time items
In Q1 FY27, IKS delivered 12% constant-currency revenue growth on just 4.2% people-cost growth, with headcount rising from 12,300 to 12,889. Management said 'the entire growth in EBITDA has been driven by operational improvements and not by currency', while framing 12%+ CC growth as an aspiration, not a guidance.
Management reaffirmed on the Q1 FY27 call that TruBridge is still expected to be EPS accretive for FY27, 'potentially even more so than initially anticipated, as the EBITDA remains the same'. Synergies are expected within 3 years post-closing.
The 'True North' target is consolidated EBITDA of at least Rs. 3,000 crores by FY30, off a combined run-rate of roughly Rs. 1,800 Cr including TruBridge's $68 Mn annualized inherited operating EBITDA. Management expressed confidence, saying 'we have a really good line of sight to that'.
Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.